0000014272-17-000058.txt : 20170223 0000014272-17-000058.hdr.sgml : 20170223 20170223192940 ACCESSION NUMBER: 0000014272-17-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170221 FILED AS OF DATE: 20170223 DATE AS OF CHANGE: 20170223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Emmens Matthew CENTRAL INDEX KEY: 0001298332 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 17634318 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_148789616778457.xml FORM 4 X0306 4 2017-02-21 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001298332 Emmens Matthew BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 0 0 0 Deferred Share Units 2017-02-21 4 A 0 2924.754 54.78 A Common Stock, $0.10 par value 2924.754 2924.754 D Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Represents pro rata portion of the 2017 annual Deferred Share Units awards granted to the Company's directors. /s/ Katherine R. Kelly, attorney-in-fact for Matthew W. Emmens 2017-02-23